Name: Krystal Biotech, Inc. (KRYS) Financial Statements
Creator: FinSpry

Krystal Biotech Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Krystal Biotech, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	290.52	50.70	0.00	0.00	0.00
Cost of Revenue	20.06	3.09	0.00	0.00	0.00
Gross Profit	270.45	47.61	0.00	0.00	0.00
Operating Expenses
Research & Development	53.57	46.43	42.46	27.88	17.94
Selling, General & Administrative	113.69	98.40	78.84	40.39	15.06
Operating Expenses	167.26	144.83	121.30	68.28	33.00
Operating Income	103.20	-97.23	-121.30	-68.28	-33.00
Other Income/Expense
Interest Income	29.66	22.62	5.22	0.20	0.83
Interest Expense	0.00	0.00	0.00	1.49	0.00
Other Income/Expense	29.66	87.50	-25.00	0.00	0.00
Income
Income Before Tax	95.36	12.90	-139.98	-69.57	-32.17
Income Tax Expense	6.20	1.97	0.00	0.00	0.00
Net Income	89.16	10.93	-139.98	-69.57	-32.17
Net Income - Continuous Operations	89.16	10.93	-139.98	-69.57	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	105.66	-91.32	-118.65	-66.23	-31.15
EBIT	103.20	-97.23	-121.30	-68.08	-33.00
Depreciation & Amortization	2.47	5.91	2.64	1.85	1.85
Earnings Per Share
Basic EPS	3.00	-	-5.00	-3.00	-2.00
Diluted EPS	3.00	-	-5.00	-3.00	-2.00
Basic Shares Outstanding	28.59	27.15	25.49	22.20	18.79
Diluted Shares Outstanding	29.74	27.75	25.49	22.20	18.79